TERRISHA FLOYD: Open Payments
NPI 1336851617 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 37 payments from 10 companies in 2025. Trend: 2023 $398 · 2024 $744 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $213 |
| ABBVIE INC. | 11 | $208 |
| Novo Nordisk Inc | 5 | $88 |
| Astellas Pharma US Inc | 3 | $76 |
| Exact Sciences Corporation | 4 | $64 |
| Lilly USA, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Corium, LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| PFIZER INC. | 1 | $19 |
Products named: Symbravo, QULIPTA, VRAYLAR, Veozah, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit, Ozempic.
Industry payments across FL — which companies pay providers there.
